Literature DB >> 19706440

TLR4-mediated expulsion of bacteria from infected bladder epithelial cells.

Jeongmin Song1, Brian L Bishop, Guojie Li, Richard Grady, Ann Stapleton, Soman N Abraham.   

Abstract

Uropathogenic Escherichia coli invade bladder epithelial cells (BECs) by direct entry into specialized cAMP regulated exocytic compartments. Remarkably, a significant number of these intracellular bacteria are subsequently expelled in a nonlytic and piecemeal fashion by infected BECs. Here, we report that expulsion of intracellular E. coli by infected BECs is initiated by the pattern recognition receptor, Toll-like receptor (TLR)4, after activation by LPS. Also, we reveal that caveolin-1, Rab27b, PKA, and MyRIP are components of the exocytic compartment, and that they form a complex involved in the exocytosis of bacteria. This capacity of TLR4 to mediate the expulsion of intracellular bacteria from infected cells represents a previously unrecognized function for this innate immune receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706440      PMCID: PMC2736405          DOI: 10.1073/pnas.0900527106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Intracellular bacterial biofilm-like pods in urinary tract infections.

Authors:  Gregory G Anderson; Joseph J Palermo; Joel D Schilling; Robyn Roth; John Heuser; Scott J Hultgren
Journal:  Science       Date:  2003-07-04       Impact factor: 47.728

Review 2.  The uroepithelium: not just a passive barrier.

Authors:  Gerard Apodaca
Journal:  Traffic       Date:  2004-03       Impact factor: 6.215

Review 3.  Morphological plasticity as a bacterial survival strategy.

Authors:  Sheryl S Justice; David A Hunstad; Lynette Cegelski; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

4.  Bactericidal activity of alveolar macrophages is suppressed by V-ATPase inhibition.

Authors:  A Bidani; B S Reisner; A K Haque; J Wen; R E Helmer; D M Tuazon; T A Heming
Journal:  Lung       Date:  2000       Impact factor: 2.584

5.  Involvement of the Rab27 binding protein Slac2c/MyRIP in insulin exocytosis.

Authors:  Laurent Waselle; Thierry Coppola; Mitsunori Fukuda; Mariella Iezzi; Aziz El-Amraoui; Christine Petit; Romano Regazzi
Journal:  Mol Biol Cell       Date:  2003-08-07       Impact factor: 4.138

6.  Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors.

Authors:  S N Abraham; J P Babu; C S Giampapa; D L Hasty; W A Simpson; E H Beachey
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

7.  Slac2-c (synaptotagmin-like protein homologue lacking C2 domains-c), a novel linker protein that interacts with Rab27, myosin Va/VIIa, and actin.

Authors:  Mitsunori Fukuda; Taruho S Kuroda
Journal:  J Biol Chem       Date:  2002-09-07       Impact factor: 5.157

8.  Bacterial penetration of bladder epithelium through lipid rafts.

Authors:  Matthew J Duncan; Guojie Li; Jeoung-Sook Shin; Johnny L Carson; Soman N Abraham
Journal:  J Biol Chem       Date:  2004-02-19       Impact factor: 5.157

9.  Identification and characterization of a gene product that regulates type 1 piliation in Escherichia coli.

Authors:  P E Orndorff; S Falkow
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

10.  Rab27b is associated with fusiform vesicles and may be involved in targeting uroplakins to urothelial apical membranes.

Authors:  Yanru Chen; Xuemei Guo; Fang-Ming Deng; Feng-Xia Liang; Wenyu Sun; Mindong Ren; Tetsuro Izumi; David D Sabatini; Tung-Tien Sun; Gert Kreibich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-18       Impact factor: 11.205

View more
  67 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 2.  [Urinary tract immunology].

Authors:  S Schubert
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

3.  Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.

Authors:  Matthew G Blango; Matthew A Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

Review 4.  Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic Bacteria.

Authors:  Peter Chahales; David G Thanassi
Journal:  Microbiol Spectr       Date:  2015-10

Review 5.  Innate Immune Responses to Bladder Infection.

Authors:  Byron W Hayes; Soman N Abraham
Journal:  Microbiol Spectr       Date:  2016-12

Review 6.  Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Authors:  Adam J Lewis; Amanda C Richards; Matthew A Mulvey
Journal:  Microbiol Spectr       Date:  2016-12

7.  Ubiquitination of Innate Immune Regulator TRAF3 Orchestrates Expulsion of Intracellular Bacteria by Exocyst Complex.

Authors:  Yuxuan Miao; Jianxuan Wu; Soman N Abraham
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

Review 8.  The nature of immune responses to urinary tract infections.

Authors:  Soman N Abraham; Yuxuan Miao
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

9.  Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder.

Authors:  Tamako A Garcia; Christy L Ventura; Mark A Smith; D Scott Merrell; Alison D O'Brien
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

10.  The Catabolite Repressor Protein-Cyclic AMP Complex Regulates csgD and Biofilm Formation in Uropathogenic Escherichia coli.

Authors:  David A Hufnagel; Margery L Evans; Sarah E Greene; Jerome S Pinkner; Scott J Hultgren; Matthew R Chapman
Journal:  J Bacteriol       Date:  2016-11-18       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.